Log in
Enquire now
BioNTech

BioNTech

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
AngelList URL
angel.co/company/biontech
B2X
B2C
B2C
B2B
B2B
0
Board of Directors
Helmut Jeggle
Helmut Jeggle
Ulrich Wandschneider
Ulrich Wandschneider
‌
Michael Motschmann
‌
Christoph Huber
Business Model
Commerce
CEO
Ugur Sahin
Ugur Sahin
CFO
‌
Jan Jens
CIK Number
1,776,985
Legal Name
BioNTech SE
Company Operating Status
Active
Competitors
Meissa Vaccines
Meissa Vaccines
Kernal Biologics
Kernal Biologics
Arcturus Therapeutics
Arcturus Therapeutics
Country
Germany
Germany
Crunchbase URL
crunchbase.com/organiz...ntech-ag
Date Incorporated
2009
Email Address
info-imfs@biontech.de
service@biontech.de
info@biontech.de
Fax Number
49 6131 9084-390
Founded Date
2008
Founder
Ugur Sahin
Ugur Sahin
‌
Christoph Huber
Full Address
40 Erie Street, Suite 110 Cambridge, MA 02139 USA
An der Goldgrube 12 55131 Mainz Germany
Weinbergweg 23 D-06120 Halle Germany
Volmerstr. 5 D-12489 Berlin Germany
Vollmersbachstr. 66 D-55743 Idar-Oberstein Germany
Leberstraße 20 1110 Vienna Austria
Forstenrieder Str. 8-14 D-82061 Neuried Germany
Emil-von-Behring-Str. 76 35041 Marburg Germany
Am Klopferspitz 19a D-82152 Planegg-Martinsried Germany
930 Clopper Rd Gaithersburg, MD 20878 USA
Headquarters
Mainz
Mainz
Industry
Drug discovery
Drug discovery
Vaccine
Vaccine
Biology
Biology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Immunotherapy
Immunotherapy
Healthcare
Healthcare
Internal medicine
Internal medicine
•••
Invested in
‌
Sortera Bio
Investors
Temasek Holdings
Temasek Holdings
Redmile Group
Redmile Group
Sanofi
Sanofi
Fidelity Investments
Fidelity Investments
European Investment Bank
European Investment Bank
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Jebsen Capital
Jebsen Capital
Invus
Invus
MIG Fonds
MIG Fonds
Janus Henderson Investors
Janus Henderson Investors
Latest Funding Round Date
September 15, 2020
Latest Funding Round Amount (USD)
455,600,000
Latest Funding Type
Private equity
Private equity
Legal classification
Incorporation (business)
Incorporation (business)
Gesellschaft mit beschränkter Haftung
Gesellschaft mit beschränkter Haftung
LinkedIn URL
@company/biontech-se
Location
Germany
Germany
Mainz
Mainz
Austria
Austria
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
San Diego
San Diego
Gaithersburg, Maryland
Gaithersburg, Maryland
Number of Employees
3,000
Number of Employees (Ranges)
1,001 – 5,000
Patents Assigned (Count)
27
Phone Number
+49613190840
Pitchbook URL
pitchbook.com/profiles.../56857-33
Place of Incorporation
Germany
Germany
Spun Out From
Johannes Gutenberg University of Mainz
Johannes Gutenberg University of Mainz
Exchange
Nasdaq
Nasdaq
Stock Symbol
BNTX
Subsidiary
PhagoMed Biopharma
PhagoMed Biopharma
Total Funding Amount (USD)
1,777,847,000
Twitter URL
@BioNTech_Group
Official Website
biontech.com
biontech.de
Wellfound ID
biontech

Find more companies like BioNTech

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.